Refractory Oropharyngeal Squamous Cell Carcinoma
2 clinical trials · Condition
◉ Watch Refractory Oropharyngeal Squamous Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers (NCT05582590) | NexImmune Inc. | 2025-03-31 |
| Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment (NCT06589804) | National Cancer Institute (NCI) | 2025-03-27 |
Track Refractory Oropharyngeal Squamous Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.